In one study, Wang et al. designed an MN containing pH-sensitive dextran nanocarriers encapsulated with an anti-programmed cell death protein-1 (PD-1) antibody (aPD1), glucose oxidase (GOx), and catalase (CAT), to treat melanoma 100. Here, PDCD1 is linked to melanoma.